← Browse by Condition
Medical Condition

metastatic salivary gland cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06805617 Phase 2
Recruiting

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

Enrollment
35 pts
Location
United States
Sponsor
Glenn J. Hanna
View Trial →